drugset / Trial / NCT03806452
SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this phase IIb, international, multicentre, double-blind, randomised, placebo-controlled study is to determine the effect of hydroxycarbamide on albuminuria after 6 months of treatment in SCD adult patients.
Timeline
- Start
- 2019-05-28
- Primary completion
- 2024-05-30
- Completion
- 2024-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxyurea | Other / unclassified | 15 mg/kg | Oral |